Yu Kang
- Cardiology and Cardiovascular Medicine top 10%
- Oncology
- Radiology, Nuclear Medicine and Imaging top 10%
- Electrical and Electronic Engineering
- Pulmonary and Respiratory Medicine
- Co-authors
- Marielle Scherrer‐CrosbieJoseph R. CarverBénédicte LefebvreAmanda M. SmithNoelle V. FreyLeilei ChengCuizhen PanMinmin Sun
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (10 papers)Cardiac Imaging and Diagnostics (9 papers)Cardiovascular Function and Risk Factors (8 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Yu Kang
25 papers receiving 433 citations
Peers
Comparison fields: 5 of 60
- Cardiology and Cardiovascular Medicine 277
- Oncology 157
- Radiology, Nuclear Medicine and Imaging 115
- Electrical and Electronic Engineering 62
- Pulmonary and Respiratory Medicine 53
Countries citing papers authored by Yu Kang
This map shows the geographic impact of Yu Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Kang more than expected).
Fields of papers citing papers by Yu Kang
This network shows the impact of papers produced by Yu Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Kang. The network helps show where Yu Kang may publish in the future.
Co-authorship network of co-authors of Yu Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Yu Kang. A scholar is included among the top collaborators of Yu Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Kang. Yu Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 17 | |
| 4 | 6 | |
| 5 | 11 | |
| 6 | 4 | |
| 7 | 112 | |
| 8 | 10 | |
| 9 | 30 | |
| 10 | 21 | |
| 11 | 11 | |
| 12 | 19 | |
| 13 | 22 | |
| 14 | 5 | |
| 15 | 15 | |
| 16 | 1 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 32 | |
| 20 | 86 |
About Yu Kang
Yu Kang is a scholar working on Cardiology and Cardiovascular Medicine, Developmental Neuroscience and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 439 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiovascular Function and Risk Factors (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (277 citations), Oncology (157 citations) and Radiology, Nuclear Medicine and Imaging (115 citations). Yu Kang has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Marielle Scherrer‐Crosbie, Joseph R. Carver, Bénédicte Lefebvre, Amanda M. Smith, Noelle V. Frey, Leilei Cheng, Cuizhen Pan, Minmin Sun, Haiyan Chen and Xianhong Shu. Their work appears in journals such as PLoS ONE, European Heart Journal and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.